Central Serous Chorioretinopathy: Pathogenesis and Management

Francesco Semeraro,1 Francesco Morescalchi,1 Andrea Russo,1 Elena Gambicorti,1 Andrea Pilotto,2 Francesco Parmeggiani,3 Silvia Bartollino,4 Ciro Costagliola4 1Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy; 2Department o...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Semeraro F, Morescalchi F, Russo A, Gambicorti E, Pilotto A, Parmeggiani F, Bartollino S, Costagliola C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	central serous chorioretinopathy acute central serous chorioretinopathy chronic central serous chorioretinopathy Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/be11d5919fdf42aa9f17621290f80712
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:be11d5919fdf42aa9f17621290f80712
record_format	dspace
spelling	oai:doaj.org-article:be11d5919fdf42aa9f17621290f807122021-12-02T05:49:52ZCentral Serous Chorioretinopathy: Pathogenesis and Management1177-5483https://doaj.org/article/be11d5919fdf42aa9f17621290f807122019-12-01T00:00:00Zhttps://www.dovepress.com/central-serous-chorioretinopathy-pathogenesis-and-management-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Francesco Semeraro,1 Francesco Morescalchi,1 Andrea Russo,1 Elena Gambicorti,1 Andrea Pilotto,2 Francesco Parmeggiani,3 Silvia Bartollino,4 Ciro Costagliola4 1Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy; 2Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Brescia, Italy; 3Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy; 4Department of Medicine and Health Science “V. Tiberio”, University of Molise, Campobasso, ItalyCorrespondence: Silvia BartollinoDepartment of Medicine and Health Science “V. Tiberio”, University of Molise, Via de Santis, Campobasso 86100, ItalyEmail silvia.bartollino@unimol.itAbstract: Central serous chorioretinopathy (CSC) is a common retina disease and has a relative high recurrence rate, etiology, and pathogenesis of which remains largely ambiguous. The effects on the retina are usually self-limited, although some people are left with permanent vision loss due to progressive and irreversible photoreceptor damage or retinal pigment epithelium atrophy. There have been a number of interventions used in CSC, including, but not limited to, laser treatment, photodynamic therapy (PDT), intravitreal injection of anti-vascular endothelial growth factor agents, and subthreshold lasers. It is not clear whether there is a clinically important benefit to treating acute CSC, which often resolves spontaneously as part of its natural history. Of the interventions studied to date, PDT and micropulse laser treatment appear the most promising.&emsp;Keywords: central serous chorioretinopathy, acute central serous chorioretinopathy, chronic central serous chorioretinopathySemeraro FMorescalchi FRusso AGambicorti EPilotto AParmeggiani FBartollino SCostagliola CDove Medical Pressarticlecentral serous chorioretinopathyacute central serous chorioretinopathychronic central serous chorioretinopathyOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 13, Pp 2341-2352 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	central serous chorioretinopathy acute central serous chorioretinopathy chronic central serous chorioretinopathy Ophthalmology RE1-994
spellingShingle	central serous chorioretinopathy acute central serous chorioretinopathy chronic central serous chorioretinopathy Ophthalmology RE1-994 Semeraro F Morescalchi F Russo A Gambicorti E Pilotto A Parmeggiani F Bartollino S Costagliola C Central Serous Chorioretinopathy: Pathogenesis and Management
description	Francesco Semeraro,1 Francesco Morescalchi,1 Andrea Russo,1 Elena Gambicorti,1 Andrea Pilotto,2 Francesco Parmeggiani,3 Silvia Bartollino,4 Ciro Costagliola4 1Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy; 2Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Brescia, Italy; 3Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy; 4Department of Medicine and Health Science “V. Tiberio”, University of Molise, Campobasso, ItalyCorrespondence: Silvia BartollinoDepartment of Medicine and Health Science “V. Tiberio”, University of Molise, Via de Santis, Campobasso 86100, ItalyEmail silvia.bartollino@unimol.itAbstract: Central serous chorioretinopathy (CSC) is a common retina disease and has a relative high recurrence rate, etiology, and pathogenesis of which remains largely ambiguous. The effects on the retina are usually self-limited, although some people are left with permanent vision loss due to progressive and irreversible photoreceptor damage or retinal pigment epithelium atrophy. There have been a number of interventions used in CSC, including, but not limited to, laser treatment, photodynamic therapy (PDT), intravitreal injection of anti-vascular endothelial growth factor agents, and subthreshold lasers. It is not clear whether there is a clinically important benefit to treating acute CSC, which often resolves spontaneously as part of its natural history. Of the interventions studied to date, PDT and micropulse laser treatment appear the most promising.&emsp;Keywords: central serous chorioretinopathy, acute central serous chorioretinopathy, chronic central serous chorioretinopathy
format	article
author	Semeraro F Morescalchi F Russo A Gambicorti E Pilotto A Parmeggiani F Bartollino S Costagliola C
author_facet	Semeraro F Morescalchi F Russo A Gambicorti E Pilotto A Parmeggiani F Bartollino S Costagliola C
author_sort	Semeraro F
title	Central Serous Chorioretinopathy: Pathogenesis and Management
title_short	Central Serous Chorioretinopathy: Pathogenesis and Management
title_full	Central Serous Chorioretinopathy: Pathogenesis and Management
title_fullStr	Central Serous Chorioretinopathy: Pathogenesis and Management
title_full_unstemmed	Central Serous Chorioretinopathy: Pathogenesis and Management
title_sort	central serous chorioretinopathy: pathogenesis and management
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/be11d5919fdf42aa9f17621290f80712
work_keys_str_mv	AT semerarof centralserouschorioretinopathypathogenesisandmanagement AT morescalchif centralserouschorioretinopathypathogenesisandmanagement AT russoa centralserouschorioretinopathypathogenesisandmanagement AT gambicortie centralserouschorioretinopathypathogenesisandmanagement AT pilottoa centralserouschorioretinopathypathogenesisandmanagement AT parmeggianif centralserouschorioretinopathypathogenesisandmanagement AT bartollinos centralserouschorioretinopathypathogenesisandmanagement AT costagliolac centralserouschorioretinopathypathogenesisandmanagement
_version_	1718400254908301312

Central Serous Chorioretinopathy: Pathogenesis and Management

Ejemplares similares